KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortization of GoodwillCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Evolent Health (EVH) Cash from Operations (2016 - 2025)

Evolent Health has reported Cash from Operations over the past 11 years, most recently at 48800000.0 for Q4 2025.

  • Quarterly results put Cash from Operations at 48800000.0 for Q4 2025, up 286.04% from a year ago — trailing twelve months through Dec 2025 was 38843000.0 (up 107.0% YoY), and the annual figure for FY2025 was 38843000.0, up 107.0%.
  • Cash from Operations for Q4 2025 was 48800000.0 at Evolent Health, up from 15812000.0 in the prior quarter.
  • Over the last five years, Cash from Operations for EVH hit a ceiling of 89381000.0 in Q4 2023 and a floor of 57442000.0 in Q1 2022.
  • Median Cash from Operations over the past 5 years was 9286500.0 (2022), compared with a mean of 11369200.0.
  • Biggest five-year swings in Cash from Operations: skyrocketed 3174.77% in 2024 and later tumbled 241.64% in 2025.
  • Evolent Health's Cash from Operations stood at 66656000.0 in 2021, then crashed by 46.45% to 35695000.0 in 2022, then skyrocketed by 150.4% to 89381000.0 in 2023, then tumbled by 129.35% to 26231000.0 in 2024, then soared by 286.04% to 48800000.0 in 2025.
  • The last three reported values for Cash from Operations were 48800000.0 (Q4 2025), 15812000.0 (Q3 2025), and 30334000.0 (Q2 2025) per Business Quant data.